179 related articles for article (PubMed ID: 37440099)
1. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
[TBL] [Abstract][Full Text] [Related]
3. The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.
Zale EL; Pierre-Louis C; Macklin EA; Riklin E; Vranceanu AM
J Neurooncol; 2018 Apr; 137(2):321-329. PubMed ID: 29275505
[TBL] [Abstract][Full Text] [Related]
4. Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.
Lester EG; Macklin EA; Plotkin S; Vranceanu AM
J Neurooncol; 2020 Apr; 147(2):451-457. PubMed ID: 32078086
[TBL] [Abstract][Full Text] [Related]
5. The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.
Vranceanu AM; Merker VL; Plotkin SR; Park ER
J Neurooncol; 2014 Oct; 120(1):103-9. PubMed ID: 25022450
[TBL] [Abstract][Full Text] [Related]
6. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
Lester EG; Gates MV; Vranceanu AM
Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
[TBL] [Abstract][Full Text] [Related]
7. The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.
McDermott K; Bakhshaie J; Brewer J; Vranceanu AM
Am J Med Genet A; 2024 Jun; 194(6):e63543. PubMed ID: 38318960
[TBL] [Abstract][Full Text] [Related]
8. Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.
Greenberg J; Carter S; Lester E; Funes CJ; Macklin EA; Plotkin S; Vranceanu AM
J Neurooncol; 2019 Dec; 145(3):561-569. PubMed ID: 31677033
[TBL] [Abstract][Full Text] [Related]
9. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
[TBL] [Abstract][Full Text] [Related]
10. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
[TBL] [Abstract][Full Text] [Related]
11. Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.
Grunberg VA; Bakhshaie J; Manglani H; Hooker J; Rochon EA; Vranceanu AM
J Clin Psychol; 2024 Feb; 80(2):456-470. PubMed ID: 38009710
[TBL] [Abstract][Full Text] [Related]
12. Home practice and quality of life among patients with neurofibromatosis randomized to a mind-body intervention.
Funes CJ; Zale EL; Luberto CM; Vranceanu AM
Complement Ther Med; 2019 Feb; 42():114-118. PubMed ID: 30670227
[TBL] [Abstract][Full Text] [Related]
13. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.
Mace RA; Doorley J; Bakhshaie J; Cohen JE; Vranceanu AM
J Neurooncol; 2021 Nov; 155(2):125-132. PubMed ID: 34570301
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.
Fishbein NS; Vranceanu AM; Mace RA
J Neurooncol; 2022 Sep; 159(3):637-646. PubMed ID: 35925531
[TBL] [Abstract][Full Text] [Related]
15. Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study.
Wang KE; Vranceanu AM; Lester EG
PLoS One; 2023; 18(12):e0295546. PubMed ID: 38127915
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of a Live Video Mind-Body Program to a Web-Based Platform for English-Speaking Adults With Neurofibromatosis: Protocol for the NF-Web Study.
Lester EG; Hopkins SW; Popok PJ; Vranceanu AM
JMIR Res Protoc; 2021 Jun; 10(6):e27526. PubMed ID: 34110294
[TBL] [Abstract][Full Text] [Related]
17. Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.
Kanaya MR; Greenberg J; Bakhshaie J; Vranceanu AM
J Neurooncol; 2024 Apr; 167(2):315-322. PubMed ID: 38409461
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial profiles of risk and resiliency in neurofibromatoses: a person-centered analysis of illness adaptation.
Bannon SM; Hopkins SW; Grunberg VA; Vranceanu AM
J Neurooncol; 2022 Feb; 156(3):519-527. PubMed ID: 35064449
[TBL] [Abstract][Full Text] [Related]
19. Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
Wei G; Farooq J; Kumar A
Dermatol Ther; 2021 Jan; 34(1):e14613. PubMed ID: 33258517
[TBL] [Abstract][Full Text] [Related]
20. Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.
Reichman M; Riklin E; Macklin E; Vranceanu AM
Contemp Clin Trials; 2020 Aug; 95():106078. PubMed ID: 32634485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]